Company · CIK 0001447028 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Arbutus Biopharma Corp · ABUS
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 FMForm 4 → | Sep 23, 8:32 pm EDT | Lindsay AndroskiPresident and CEO, Director | 209,391 | $4.00 | $836,819 | 72,337 | — | late |
| Sep 18, 2026 FMForm 4 → | Sep 23, 8:31 pm EDT | Tuan NguyenChief Financial Officer | 499,737 | $4.19 | $2,095,296 | 159,963 | — | late |
| Sep 18, 2026 FMForm 4 → | Sep 23, 8:31 pm EDT | Roger SawhneyDirector | 231,841 | $4.40 | $1,019,148 | 30,825 | — | late |
| Sep 18, 2026 FMForm 4 → | Sep 23, 8:31 pm EDT | Robert A BeardsleyDirector | 230,390 | $4.36 | $1,004,437 | 32,276 | — | late |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 18, 2026 MForm 4 → | Sep 23, 8:32 pm EDT | Lindsay AndroskiPresident and CEO, Director | 126,864 | — | — | 61,244 | — | late |
| Sep 18, 2026 MForm 4 → | Sep 23, 8:31 pm EDT | Tuan NguyenChief Financial Officer | 293,100 | — | — | 160,925 | — | late |
| Sep 18, 2026 MForm 4 → | Sep 23, 8:31 pm EDT | Roger SawhneyDirector | 131,333 | — | — | 0 | — | late |
| Sep 18, 2026 MForm 4 → | Sep 23, 8:31 pm EDT | Robert A BeardsleyDirector | 131,333 | — | — | 0 | — | late |
| Jun 8, 2026 AForm 4 → | Jun 10, 4:05 pm EDT | Roger SawhneyDirector | 78,800 | — | — | 78,800 | — | |
| Jun 8, 2026 AForm 4 → | Jun 10, 4:05 pm EDT | Robert A BeardsleyDirector | 78,800 | — | — | 78,800 | — |